Made possible through funding support from Q4HE, Puerto Rico’s first post-COVID-19 Care Clinic was opened by SIM, and a growing number of patients experiencing long COVID symptoms have been receiving critical tailored care.
Now, forty years after the first monoclonal antibody therapy emerged, new indications and therapy types such as antibody drug conjugates (ADCs), bispecific antibodies, and multispecific antibodies are revolutionizing treatment options.
In his opening remarks for the fourth installment of the Birmingham Legal Leaders DEI series, Regions Chief Governance Officer Andrew Nix referenced a Harvard Business Review article about how sharing our stories builds inclusion.
Business leaders know they need to take action to run more sustainably, but many aim only for regulatory compliance and avoid the steps to deeper business transformation.